Gevo (GEVO) director receives 70,000-share restricted stock grant, now holding 132,821

Rhea-AI Filing Summary

Ellet Mary Kathryn reported acquisition or exercise transactions in this Form 4 filing.

Gevo, Inc. director Mary Kathryn Ellet reported receiving a grant of 70,000 shares of common stock as equity compensation. The award was priced at $0.00 per share, indicating it is a restricted stock grant rather than an open-market purchase.

The restricted common stock will vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date, provided Ellet remains in continuous service with Gevo through the vesting date. Following this award, she directly holds 132,821 shares of Gevo common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ellet Mary Kathryn

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	70,000	$0.00	--

Holdings After Transaction: Common Stock — 132,821 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 70,000 shares Grant price: $0.00 per share Holdings after grant: 132,821 shares

3 metrics

Restricted stock grant 70,000 shares Common Stock award to director on May 27, 2026

Grant price $0.00 per share Indicates equity compensation, not open-market purchase

Holdings after grant 132,821 shares Total direct ownership following the transaction

Key Terms

restricted common stock, annual meeting of stockholders, continuous service, vesting date, +1 more

5 terms

restricted common stock financial

"Represents restricted common stock that vests on the earlier to occur of..."

Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.

annual meeting of stockholders financial

"vests on the earlier to occur of (i) the next annual meeting of stockholders..."

continuous service financial

"provided that the reporting person remains in continuous service with the issuer..."

vesting date financial

"remains in continuous service with the issuer as of the vesting date."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ellet Mary Kathryn

(Last) (First) (Middle)

C/O GEVO, INC., 345 INVERNESS DRIVE S

BUILDING C, SUITE 310

(Street)

ENGLEWOOD COLORADO 80112

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gevo, Inc. [ GEVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	05/27/2026		A		70,000	A	$0	132,821	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted common stock that vests on the earlier to occur of (i) the next annual meeting of stockholders or (ii) the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer as of the vesting date.

Remarks:

	/s/ E. Cabell Massey, Attorney-in-Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Gevo (GEVO) director Mary Kathryn Ellet report?

Gevo director Mary Kathryn Ellet reported receiving a grant of 70,000 shares of common stock. The shares were awarded at $0.00 per share as restricted stock, reflecting equity-based compensation rather than an open-market purchase, and increasing her direct holdings in the company.

Is the recent Gevo (GEVO) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a stock grant, not a market purchase. Mary Kathryn Ellet received 70,000 shares of restricted common stock at $0.00 per share as compensation, classified as a “grant, award, or other acquisition” rather than an open-market buy order.

When do Mary Kathryn Ellet’s 70,000 Gevo (GEVO) restricted shares vest?

The 70,000 restricted shares vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date. Vesting is conditional on Ellet remaining in continuous service with Gevo through that vesting date, according to the footnote disclosure.

How many Gevo (GEVO) shares does Mary Kathryn Ellet hold after this Form 4 transaction?

After the reported grant, Mary Kathryn Ellet directly holds 132,821 shares of Gevo common stock. This total includes the 70,000-share restricted stock award and reflects her direct ownership position as disclosed in the Form 4 following the acquisition.

What does the $0.00 per share price mean in Gevo (GEVO) director’s Form 4?

The $0.00 per share price signals that the 70,000 shares were granted as restricted stock, not bought in the market. It represents equity compensation provided by Gevo, with value realized based on future vesting and the company’s stock price performance at or after vesting.